mRNA vaccines have evolved as promising cancer therapies. These vaccines can encode
tumor-allied antigens, thus enabling personalized treatment approaches. They can also …

Pulmonary fibrosis (PF) is a progressive, and life-threatening interstitial lung disease which
causes scarring in the lung parenchyma and thereby affects architecture and functioning of …

The lymphatic system has garnered significant attention in drug delivery research due to the
advantages it offers, such as enhancing systemic exposure and enabling lymph node …

Abstract mRNA-based vaccines are emerging as a promising alternative to standard cancer
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …

Nanoparticle-based cancer immunotherapy has shown promising therapeutic potential in
clinical settings. However, current research mainly uses nanoparticles as delivery vehicles …

Owing to their outstanding performance against COVID-19, mRNA vaccines have brought
great hope for combating various incurable diseases, including cancer. Differences in the …

Since the approval of the lipid nanoparticles (LNP)-mRNA vaccines against the SARS-CoV-
2 virus, there has been an increased interest in the delivery of mRNA through LNPs …

RNA‐based therapeutics have gained traction for the prevention and treatment of a variety
of diseases. However, their fragility and immunogenicity necessitate a drug carrier. Lipid …

To unlock the full promise of messenger (mRNA) therapies, expanding the toolkit of lipid
nanoparticles is paramount. However, a pivotal component of lipid nanoparticle …

Adjuvanticity and delivery are crucial facets of mRNA vaccine design. In modern mRNA
vaccines, adjuvant functions are integrated into mRNA vaccine nanoparticles, allowing the …